Bio Blast Pharma Aktie
1,37
EUR
+0,59
EUR
+75,64
%
1,28
USD
+0,39
USD
+43,63
%
Werbung
Bio Blast Pharma Aktie Analyse
| 28.01.16 | Bio Blast Pharma Buy | Rodman & Renshaw, LLC | |
| 09.12.15 | Bio Blast Pharma Buy | ROTH Capital Partners, LLC | |
| 15.06.15 | Bio Blast Pharma Buy | ROTH Capital Partners, LLC | |
| 08.01.15 | Bio Blast Pharma Buy | ROTH Capital Partners, LLC |
Werbung
Werbung